Curia (company)

Last updated
Curia
Industry Pharmaceuticals
Founded1991
FounderThomas D'Ambra
Headquarters Albany, New York, U.S.
Key people
John Ratliff (Chairman & CEO)
Jason Knoblauch (CFO)
RevenueIncrease2.svg $276.6 million (2014) [1]
Decrease2.svg -$3.3 million (2014) [1]
Total assets Increase2.svg $520 million (2014) [1]
Total equity Increase2.svg $241.8 million (2014) [1]
Website curiaglobal.com

Curia (formerly AMRI or Albany Molecular Research Inc. [2] ) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, Curia operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. Curia has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Contents

Company history and acquisitions

Inaugurated in 1991 as Albany Molecular Research, Inc., AMRI was founded by Thomas E. D’Ambra, Ph.D. and Chester Opalka. As AMRI, the company was a publicly traded company on the NASDAQ from 1999 until 2017. [3] AMRI commenced operations with custom synthesis services in laboratory space provided by Siena College. Following this, the company expanded into laboratory space at the Wright Malta Corporation, which was located on the site where Global Foundries new computer chip fabrication plant is located. [4] After that, in early 1992, the company consolidated and expanded its operations into laboratory space at the Rensselaer Polytechnic Institute Incubator Annex in Watervliet N.Y. By 1997, the company occupied laboratory space in the C-wing of the SUNY Albany East Campus, which was formerly the Sterling Winthrop Research Institute. [5] In 1999, through the purchase of Enzymed Inc. (Iowa City, IA), the company added biocatalysis capabilities [6] before, AMRI acquired American Advanced Organics, Inc. of Syracuse N.Y. in 2000. [7] In 2001, the company added natural product isolation and identification technology through the acquisition of New Chemical Entities of Bothell, WA. [8] In early 2001, AMRI began leasing space in 30 Corporate Circle, which was fitted out as discovery chemistry laboratory space. The company then purchased two buildings at 24 and 26 Corporate Circle. The original building at 26 was demolished. Construction on a new 26 Corporate Circle building began in November 2002 and AMRI’s new Corporate Headquarters was opened in April 2004. [9]

AMRI went on to establish offshore subsidiaries, which included the Albany Molecular Research Singapore Research Centre, Pte. Ltd., located in Singapore, and the Albany Molecular Research Hyderabad Research Centre, Pvt. Ltd., located in India (both in 2005). [10] AMRI acquired the Budapest operations of ComGenex in March 2006. [11] In May 2007, the company officially changed its name to AMRI and introduced a new company logo. [12] AMRI acquired a number of API and chemical intermediates manufacturing facilities from Ariane Orgachem in Aurangabad, India in 2008 [13] then in 2010 AMRI completed the acquisition of Excelsyn in Holywell, U.K. [14] This facility underwent successful inspections by the U.S. Food and Drug Association (FDA) in June 2011, and the UK Medicines and Healthcare products Regulatory Agency (MHRA) in January 2012 allowing for the production of registered intermediates and APIs for human use. [15] After this AMRI expanded into the aseptic fill and finish business, acquiring the parenteral dosage form manufacturing business Hyaluron, located in Burlington, Massachusetts (USA). [16] In early 2012, the company ended operations in Budapest, Hungary, moving most of the operations to the new parallel synthesis and purification laboratories Hyderabad facility. [17] In November 2012, AMRI announced that it would close the Bothell, Washington, site and would transition the sites biology capabilities to Singapore. [18] In December 2012, New York State announced plans to invest $50 million in biomedical research equipment and facilities and secured an agreement with AMRI to locate a new drug discovery R&D facility at the Buffalo Niagara Medical Campus. [19] In December 2012, AMRI Rensselaer was awarded a $200,000 Empire State Development Corporation grant for the expansion of the diagnostic imaging agent project. [20]

AMRI completed an initial public offering in February 1999, raising $56.3 million and listing as AMRI on the Nasdaq. [21] The company also completed a secondary public offering in October 2000, generating further net proceeds of $119.5 million. [22] AMRI’s Allegra patent applications, from 1995, and the resulting patents were licensed to what is now Sanofi-Aventis. The company continues to receive royalties on the sale of Allegra and Telfast products globally. [23]

In June 2014, AMRI acquired OsoBio Pharmaceuticals, a contract manufacturer specializing in aseptic filling, for $110 million. [24]

In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26]

In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]

In June 2017 management of AMRI and two private equity firms, The Carlyle Group and GTCR, agreed to sell AMRI to the firms for $21.75 per share, around $1.5 billion, taking the company private. AMRI was weighed down with debt from recent acquisitions and was struggling to make a profit; the arrangement awaited approval of shareholders and regulators. [28] This agreement was part of a burst of M&A activity in the CRO industry, with Lonza Group acquiring Capsugel for around $5.5 billion and Thermo Fisher Scientific buying Patheon for $7.2 billion. [28]

In July 2021, AMRI changed its name to Curia [2]

In September 2021, the company acquired Integrity Bio and LakePharma, a biologics research, development, and manufacturing organization, for undisclosed amounts. LakePharma's co-founder and CEO, Hua Tu, joined Curia's executive team as the Chief Technology Officer. [29] [30]

Scientific collaborations

In July 1997, AMRI received a $100,000 grant from the National Cancer Institute to “design and synthesize compounds that inhibit a class of enzymes responsible for regulation of the cell cycle”. [31] AMRI then extended a deal in 2001 with Pfizer for three additional years to “provide chemistry, research, development and analytical services”. [32] AMRI entered into a 3-year deal with Merck and Co. to “perform medicinal chemistry research and help design and synthesize compounds” in June 2002 [9] before, in May 2004, AMRI was awarded a three-year contract to manufacture potential treatments for substance abuse by the National Institute of Drug Abuse. [33] In April 2007, AMRI took a lead role in a three-year, multidisciplinary research program, the CancerGrid Project, funded by the European Commission. [34] and went on to receive a multi-year National Institutes of Health (NIH) contract Award for the “development of pre-clinical drug candidates to treat diseases of the nervous system” in August 2011. [35]

In October 2012, AMRI announced a five-year extension of an API supply agreement with Shire for an undisclosed product. [36] In December 2012, AMRI announced a multi-year extension of a commercial supply relationship with GE Healthcare to provide Aminobisamide (ABA), a key intermediate used in several diagnostic imaging agents. [37]

Awards and nominations

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

<span class="mw-page-title-main">Labcorp Drug Development</span> Contract research organization

Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

<span class="mw-page-title-main">Fine chemical</span> Pure chemical substances produced by and for the chemical industry

In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Cambrex Corporation</span> American pharmaceutical company

Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets for API and dosage form development and manufacturing.

<span class="mw-page-title-main">Thermo Fisher Scientific</span> Provisioner of scientific consumables, equipment, and services

Thermo Fisher Scientific Inc. is an American-headquartered company and global supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).

A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

<span class="mw-page-title-main">Therapure BioPharma Inc</span>

Therapure BioPharma, Inc. is a Canadian biopharmaceutical industry and biotechnology company, headquartered in Mississauga, Ontario, a privately held, integrated Contract Development and Manufacturing Organization (CDMO). Founded in 2008, the firm provides a range of therapeutic protein development and manufacturing services including; technology transfer & process development, analytical development and testing, scale up and cGMP manufacturing, and aseptic fill/finish and lyophilization. As of 2010, the company has over 90 employees. In 2020, Therapure was acquired by Resilience.

<span class="mw-page-title-main">Evotec</span> German biopharmaceutical company

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.

<span class="mw-page-title-main">Intas Pharmaceuticals</span> Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. It's market presence is more than 100+ countries.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

<span class="mw-page-title-main">Amneal Pharmaceuticals</span> American publicly traded generics and specialty pharmaceutical company

Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

<span class="mw-page-title-main">Scientist.com (company)</span> Network of e-commerce marketplaces

Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. The company was founded in 2007 by Kevin Lustig, Chris Petersen and Andrew Martin and launched its first public research marketplace in September 2008.

Taconic Biosciences is a private biotechnology company specializing in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services. The company was founded in 1952 as Taconic Farms. The company has three service laboratories and six breeding facilities in the U.S. and Europe, and is headquartered in Rensselaer, New York.

<span class="mw-page-title-main">ApiJect Systems</span>

ApiJect Systems Corporation is an American company founded in 2018 by Marc Koska and based in Stamford, Connecticut that produces pre-filled single use plastic injectors. ApiJect works with pharmaceutical and biotech companies to fill their injectable drug products into single-dose prefilled injectors. The company claimed to have the capacity to manufacture pre-filled COVID-19 vaccine syringes by the end of 2020.

References

  1. 1 2 3 4 "Archived copy" (PDF). files.shareholder.com. Archived from the original (PDF) on 22 July 2015. Retrieved 17 January 2022.{{cite web}}: CS1 maint: archived copy as title (link)
  2. 1 2 "AMRI becomes Curia". Curia. Retrieved 3 March 2024.
  3. ↑ Editorial, Reuters. "Company Search Results". U.S.{{cite web}}: |first= has generic name (help)
  4. ↑ "Resource Library - National Business Incubation Association". Archived from the original on 2013-08-31. Retrieved 2013-07-08.
  5. ↑ A slip of the pen – The Business Review
  6. ↑ "6452-BARCLAY6452-BARCLAYICIS Login". id.icis.com.
  7. ↑ "Albany Molecular Acquires American Advanced Organics". www.pharmaceuticalonline.com.
  8. ↑ New Chemical Entities purchase completed – Puget Sound Business Journal
  9. 1 2 Albany Molecular buys building for $1.3M - The Business Review
  10. ↑ "Albany Molecular Research, Inc. Establishes Singapore Research Centre". www.chemeurope.com.
  11. ↑ "AMRI Hungary-re változott a ComGenex neve - Menedzsment Fórum, mfor.hu". Archived from the original on 2016-11-21. Retrieved 2013-07-08.
  12. ↑ New name for Albany Molecular reflects broader services – The Business Review
  13. ↑ AMRI expands in India – The Business Review
  14. ↑ AMRI acquires Wales chemical company – The Business Review
  15. ↑ "MHRA Issues GMP Certification to AMRI UK Facility". www.bionity.com.
  16. ↑ AMRI buys Mass. drug manufacturer for $27M - The Business Review
  17. ↑ outsourcing-pharma.com. "AMRI to end operations at Hungary site by next Friday". outsourcing-pharma.com.
  18. ↑ outsourcing-pharma.com. "AMRI to close Bothell site and shift work to Singapore". outsourcing-pharma.com.
  19. ↑ "Governor Cuomo Presented with Buffalo Billion Investment Development Plan". Governor Andrew M. Cuomo. 28 September 2014. Archived from the original on 3 June 2019. Retrieved 3 June 2019.
  20. ↑ http://capitalregionopenforbusiness.com/Libraries/Documents/PriorityProjectsNarrative09_10_12.sflb.ashx [ permanent dead link ]
  21. ↑ Albany Molecular's IPO underwriters buy over-allotment shares - The Business Review
  22. ↑ Abany Molecular opens stock sale – The Business Review
  23. ↑ "HMR licenses Albany Molecular's TAM patents :: Strategic Transactions :: Pharma & Medtech Business Intelligence". www.pharmamedtechbi.com.
  24. ↑ Brennan, Zachary (3 June 2014). "AMRI buys commercial manufacturer OsoBio for $110m". Outsourcing-Pharma.com.
  25. ↑ "About SSCI". ssci-inc.com. Retrieved 2015-12-19.
  26. ↑ "AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses". www.prnewswire.com. Retrieved 2015-12-19.
  27. ↑ "AMRI Acquires Gadea for $174M". 16 July 2015.
  28. 1 2 McCoy, Michael (June 12, 2017). "Contract manufacturer AMRI to go private". Chemical & Engineering News.
  29. ↑ "Curia Completes Acquisition of LakePharma". www.businesswire.com. 2021-09-02. Retrieved 2023-02-07.
  30. ↑ "Curia Completes Acquisition of Integrity Bio". www.businesswire.com. 2021-08-04. Retrieved 2023-02-09.
  31. ↑ Local firm gets grant from National Cancer Institute – The Business Review
  32. ↑ "Albany Molecular signs new pact with Pfizer". American City Business Journals . 2001-12-17. Archived from the original on 2018-09-19.
  33. ↑ Albany Molecular gets $3M contract for drug abuse treatment - The Business Review
  34. ↑ Lead role for Albany Molecular in international drug discovery effort – The Business Review
  35. ↑ AMRI awarded NIH contract worth as much as $43M - The Business Review
  36. ↑ AMRI Announces Five-Year Extension Of API Supply Agreement With Shire - TheStreet
  37. ↑ "AMRI Extends Long Term Supply Relationship with GE Healthcare". Research & Development. 6 December 2012.
  38. ↑ Albany Molecular CEO was finalist for entrepreneur award – The Business Review
  39. 1 2 "2007 April Archive - The Buzz: Business news - page 5". blog.timesunion.com.
  40. ↑ "AMRI receives Pfizer Route Design Innovation Award". www.manufacturingchemist.com.
  41. ↑ "CMO Leadership Awards". www.cmoleadershipawards.com.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.